InsiderSignalSign in
← Insider buys

CRMD

CorMedix Inc. · Healthcare

Insiders bought $276K of CorMedix Inc. in the last 12 months

1 insider bought on 1 day.

$276KBought, 12 mo
$2.3MSold, 12 mo
$611.9MMarket cap
Follow CRMD

CRMD over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

CRMD after insider buys

3 months after each buy, from the first price a copier could get.

−11.2%Average
−15.3 ptsVs S&P 500
1 of 5Higher

5 buys since 2017 with 3 months of prices.

Every filing

52 insider filings since 2016, newest first

CRMDSell

Janet Dillione · Director

$69K−21.0%Jan 22
CRMDSell

Alan W Dunton · Director

$260K−33.0%Jan 2
CRMDSell

Joseph Todisco · CEO

$360K−6.0%Dec 19
CRMDSell

Janet Dillione · Director

$408K−41.0%Dec 11
CRMDSell

Steven W Lefkowitz · Director

$475K−26.0%Dec 10
CRMDSell

Janet Dillione · Director

$467K−49.0%Dec 4
CRMDSell

Janet Dillione · Director

$262K−35.0%Nov 26
CRMDBuy

Myron Kaplan · Director

$276K+12.0%Oct 27
CRMDSell

Elizabeth Hurlburt · EVP

$1.6M−76.0%Nov 18
CRMDBuy

Joseph Todisco · CEO

$37K+5.0%Sep 8
CRMDBuy

Myron Kaplan · Director

$27K+3.0%May 19
CRMDBuy

Paulo F Costa · Director

$47KMay 18
CRMDBuy

Robert A Stewart · Director

$44KMay 18
CRMDBuy

Joseph Todisco · CEO

$34K+2.0%May 17
CRMDBuy

Myron Kaplan · Director

$51K+6.0%Nov 19
CRMDSell

Elizabeth Masson-Hurlburt · EVP, Head of Clinical Ops

$55K−100.0%May 25
CRMDBuy

Myron Kaplan · Director

$65K+11.0%Sep 4
CRMDBuy

Mehmood Khan · Director

$221K+34.0%Aug 20
CRMDBuy

Jr. John L. Armstrong · EVP of Tech Operations

$116K+40.0%Aug 17
CRMDBuy

Myron Kaplan · Director

$61K+13.0%Aug 17
CRMDBuy

Myron Kaplan · Director

$39K+9.0%May 18
CRMDBuy

Steven W Lefkowitz · Director

$34K+6.0%Oct 1
CRMDBuy

Myron Kaplan · Director

$34K+5.0%Oct 1
CRMDBuy

Janet Dillione · Director

$75K+31.0%May 17
CRMDBuy

Jr. John L. Armstrong · EVP of Tech Operations

$25K+5.0%Mar 25
CRMDBuy

Myron Kaplan · Director

$33K+4.0%Mar 22
CRMDBuy

Janet Dillione · Director

$70K+30.0%Mar 20
CRMDBuy

Mehmood Khan · Director

$124K+22.0%Dec 21
CRMDBuy

Myron Kaplan · Director

$73K+13.0%Dec 17
CRMDBuy

Jr. John L. Armstrong · EVP of Tech Operations

$363K+643.0%Nov 30
CRMDBuy

Khoso Baluch · CEO

$30K+12.0%Nov 27
CRMDBuy

Robert W. Cook · CFO

$29K+24.0%Nov 27
CRMDBuy

Myron Kaplan · Director

$65K+16.0%Nov 27
CRMDBuy

Mehmood Khan · Director

$25K+13.0%Dec 14
CRMDBuy

Myron Kaplan · Director

$50K+58.0%Dec 14
CRMDBuy

Steven W Lefkowitz · Director

$65K+73.0%Dec 14
CRMDBuy

Janet Dillione · Director

$25K+130.0%Dec 14
CRMDBuy

Gary A. Gelbfish · Director

$25K+3.0%Dec 14
CRMDBuy

Robert W. Cook · CFO

$25K+104.0%Dec 14
CRMDBuy

Khoso Baluch · CEO

$50K+86.0%Dec 14
CRMDBuy

Mehmood Khan · Director

$158KAug 22
CRMDBuy

Myron Kaplan · Director

$32K+80.0%Aug 21
CRMDBuy

Khoso Baluch · CEO

$36K+750.0%May 19
CRMDSell

Antony Pfaffle · Chief Scientific Officer

$45K−100.0%Oct 25
CRMDSell

Antony Pfaffle · Interim Chief Medical Officer

$63K−100.0%Jun 22
CRMDSell

Matthew Duffy · Director

$126K−62.0%Jun 6
CRMDSell

Steven W Lefkowitz · Director

$144K−14.0%Jun 1
CRMDSell

Antony Pfaffle · Interim Chief Medical Officer

$35K−100.0%May 25
CRMDSell

Antony Pfaffle · Interim Chief Medical Officer

$43K−100.0%May 24
CRMDSell

Steven W Lefkowitz · Director

$88K−8.0%May 23
Older filings
About CorMedix Inc.

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.